Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: Role of transglutaminases

Journal of Vascular Research

Volumn 45, Issue 1, 2007, Pages 10-18

  Pistea, Adrian ^a   Bakker, Erik N T P ^a   Spaan, Jos A E ^a   Hardeman, Max R ^a   Van Rooijen, Nico ^b   VanBavel, Ed ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Coagulation factor XIII; Erythrocyte deformability; Hypertension; Knockout mice; Nitric oxide; Resistance arteries; Transglutaminase; Vascular remodeling

Indexed keywords

BLOOD CLOTTING FACTOR 8; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY WALL; ARTICLE; BLOOD VESSEL PARAMETERS; CONTROLLED STUDY; DEPLETION; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; FEMALE; HYPERTENSION; KNOCKOUT MOUSE; MACROPHAGE; MALE; MESENTERIC ARTERY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RIGIDITY; SMALL ARTERY REMODELING; STRESS; WILD TYPE;

ANIMALS; BLOOD PRESSURE; CLODRONIC ACID; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; ERYTHROCYTE DEFORMABILITY; FACTOR XIII; GTP-BINDING PROTEINS; HEMATOCRIT; HYPERTENSION; MACROPHAGES; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RESEARCH DESIGN; STRESS, MECHANICAL; TIME FACTORS; TRANSGLUTAMINASES;

EID: 37249060624     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109073     Document Type: Article

References (45)

1. Bund SJ, Lee RM: Arterial structural changes in hypertension: a consideration of methodology, terminology and functional consequence. J Vasc Res 2003;40:547-557.
2. Schiffrin EL: Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004;17:1192-1200.
3. Esposito C, Caputo I: Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. FEBS J 2005;272:615-631.
4. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HAJ: Microcirculation in hypertension: a new target for treatment? Circulation 2001;104:735-740.
5. Rizzoni D, Porteri E, Boari GE, De CC, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E: Prognostic significance of small-artery structure in hypertension. Circulation 2003;108:2230-2235.
6. Meiselman HJ: Hemorheologic alterations in hypertension: chicken or egg? Clin Hemorheol Microcirc 1999;21:195-200.
7. Chien S: Red cell deformability and its relevance to blood flow. Annu Rev Physiol 1987;49:177-192.
8. Lorand L, Graham RM: Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003;4:140-156.
9. Dominiczak AF, Bohr DF: Vascular smooth muscle in hypertension. J Hypertens Suppl 1989;7:S107-S115.
10. 2+ concentration in essential hypertension. Hypertension 1992;19:167-174.
11. AbdAlla S, Lother H, Langer A, el Faramawy Y, Quitterer U: Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 2004;119:343-354.
12. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MJ, VanBavel E: Small artery remodeling depends on tissue-type transglutaminase. Circ Res 2005;96:119-126.
13. Pistea A, Bakker ENTP, Spaan JAE, VanBavel E: Flow inhibits inward remodeling in cannulated porcine small coronary arteries. Am J Physiol Heart Circ Physiol 2005;289:H2632-H2640.
14. Bernassola F, Rossi A, Melino G: Regulation of transglutaminases by nitric oxide. Ann NY Acad Sci 1999;887:83-91.
15. Bakker ENTP, Pistea A, Spaan JAE, Rolf T, de Vries CJ, van Rooijen N, Candi E, VanBavel E: Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase. Possible compensation by macrophage-derived factor XIII. Circ Res 2006;99:86-92.
16. Luvara G, Pueyo ME, Philippe M, Mandet C, Savoie F, Henrion D, Michel JB: Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism. Arterioscler Thromb Vasc Biol 1998;18:1408-1416.
17. Roth WJ, Fleit HB, Chung SI, Janoff A: Characterization of two distinct transglutaminases of murine bone marrow-derived macrophages: effects of exposure of viable cells to cigarette smoke on enzyme activity. J Leukoc Biol 1987;42:9-20.
18. Van Rooijen N, Sanders A: Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174:83-93.
19. Bakker EN, Der Meulen ET, Spaan JA, VanBavel E: Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling. Am J Physiol Heart Circ Physiol 2000;278:H1233-H1240.
20. Hardeman MR, Goedhart PT, Dobbe JG: Laser-assisted optical rotational cell analyzer (LORCA): a new instrument for measurement of various structural hemorheological parameters. Clin Hemorheol 1994;14:605-618.
21. Streekstra GJ, Zwaginga JJ, Nijhof E, Sixma J, Heethaar RM: The relation between blood viscosity and plasma viscosity in the nephrotic syndrome. Clin Hemorheol 1994;14:769-778.
22. Bronkhorst P, Nijhof E, Sixma J: Parametrization of the deformation curve as a tool for standardization and interpretation of ektacytometric measurements. Clin Hemorheol 1995;15:803-816.
23. Bouvet C, Gilbert LA, Girardot D, Deblois D, Moreau P: Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition. Hypertension 2005;45:432-437.
24. Ceiler DL, De Mey JG: Chronic N(G)-nitro-L-arginine methyl ester treatment does not prevent flow-induced remodeling in mesenteric feed arteries and arcading arterioles. Arterioscler Thromb Vasc Biol 2000;20:2057-2063.
25. Girardot D, Demeilliers B, Deblois D, Moreau P: ERK1/2-mediated vasoconstriction normalizes wall stress in small mesenteric arteries during NOS inhibition in vivo. J Cardiovasc Pharmacol 2003;42:339-347.
26. Tuttle JL, Nachreiner RD, Bhuller AS, Condict KW, Connors BA, Herring BP, Dalsing MC, Unthank JL: Shear level influences resistance artery remodeling: wall dimensions, cell density, and eNOS expression. Am J Physiol Heart Circ Physiol 2001;281:H1380-H1389.
27. Hilgers RH, Schiffers PM, Aartsen WM, Fazzi GE, Smits JF, De Mey JG: Tissue angiotensin-converting enzyme in imposed and physiological flow-related arterial remodeling in mice. Arterioscler Thromb Vasc Biol 2004;24:892-897.
28. Deng LY, Schiffrin EL: Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol 1992;262:H1782-H1787.
29. Briones AM, Xavier FE, Arribas SM, Gonzalez MC, Rossoni LV, Alonso MJ, Salaices M: Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats. Am J Physiol Heart Circ Physiol 2006;291:H193-H201.
30. Bakker EN, Sorop O, Spaan JA, VanBavel E: Remodeling of resistance arteries in organoid culture is modulated by pressure and pressure pulsation and depends on vasomotion. Am J Physiol Heart Circ Physiol 2004;286:H2052-H2056.
31. Placier S, Boffa JJ, Dussaule JC, Chatziantoniou C: Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice. Nephrol Dial Transplant 2006;21:881-888.
32. VanBavel E, Bakker EN, Pistea A, Sorop O, Spaan JA: Mechanics of microvascular remodeling. Clin Hemorheol Microcirc 2006;34:35-41.
33. Mulvany MJ: Structural abnormalities of the resistance vasculature in hypertension. J Vasc Res 2003;40:558-560.
34. Fenger-Gron J, Mulvany MJ, Christensen KL: Intestinal blood flow is controlled by both feed arteries and microcirculatory resistance vessels in freely moving rats. J Physiol 1997;498:215-224.
35. Lorand L, Conrad SM: Transglutaminases. Mol Cell Biochem 1984;58:9-35.
36. Griffin M, Casadio R, Bergamini CM: Transglutaminases: nature's biological glues. Biochem J 2002;368:377-396.
37. Torocsik D, Bardos H, Nagy L, Adany R: Identification of factor XIII-A as a marker of alternative macrophage activation. Cell Mol Life Sci 2005;62:2132-2139.
38. Ma J, Chen T, Mandelin J, Ceponis A, Miller NE, Hukkanen M, Ma GF, Konttinen YT: Regulation of macrophage activation. Cell Mol Life Sci 2003;60:2334-2346.
39. Yu Q, Horak K, Larson DF: Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension 2006;48:98-104.
40. Sandhagen B, Frithz G, Waern U, Ronquist G: Increased whole blood viscosity combined with decreased erythrocyte fluidity in untreated patients with essential hypertension. J Intern Med 1990;228:623-626.
41. Cicco G, Carbonara MC, Stingi GD, Pirrelli A: Cytosolic calcium and hemorheological patterns during arterial hypertension. Clin Hemorheol Microcirc 2001;24:25-31.
42. Lorand L, Siefring GE Jr, Lowe-Krentz L: Enzymatic basis of membrane stiffening in human erythroyctes. Semin Hematol 1979;16:65-74.
43. 2+ -regulated enzyme in intact erythrocytes. J Supramol Struct 1978;9:427-440.
44. Secomb TW, Hsu R: Red blood cell mechanics and functional capillary density. Int J Microcirc Clin Exp 1995;15:250-254.
45. Antonios TFT, Singer DRJ, Markandu ND, Mortimer PS, MacGregor GA: Structural skin capillary rarefaction in essential hypertension. Hypertension 1999;33:998-1001.